Cytotoxic T-cell and NK-cell Lymphomas Current Questions and Controversies

被引:2
|
作者
Swerdlow, Steven H. [1 ]
Jaffe, Elaine S. [2 ]
Brousset, Pierre [5 ]
Chan, John K. C. [7 ]
de Leval, Laurence [8 ]
Gaulard, Philippe [6 ]
Harris, Nancy Lee [3 ]
Pileri, Stefano [9 ]
Weiss, Lawrence M. [4 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Div Hematopathol, Pittsburgh, PA USA
[2] NCI, Bethesda, MD 20892 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[4] Clarient Diagnost Serv Inc, Aliso Viejo, CA USA
[5] IUC T Oncopole, Toulouse, France
[6] Univ Paris Est, Hop Henri Mondor, Dept Pathol, Inserm,U955, Creteil, France
[7] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
[8] Univ Hosp Lausanne CHUV, Inst Pathol, Lausanne, Switzerland
[9] Univ Bologna, Sch Med, St Orsola Policlin, Bologna, Italy
关键词
cytotoxic T-cell lymphoma; gamma delta T cells; natural killer cells; enteropathy-associated T-cell lymphoma; EPSTEIN-BARR-VIRUS; NATURAL-KILLER-CELL; NON-HODGKINS-LYMPHOMA; GAMMA-DELTA; NASAL-TYPE; ALPHA-BETA; CLINICOPATHOLOGICAL FEATURES; LYMPHOPROLIFERATIVE DISORDER; INTESTINAL LYMPHOMA; LENNERTS LYMPHOMA;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The cytotoxic T-cell and natural killer (NK)-cell lymphomas and related disorders are important but relatively rare lymphoid neoplasms that frequently are a challenge for practicing pathologists. This selective review, based on a meeting of the International Lymphoma Study Group, briefly reviews T-cell and NK-cell development and addresses questions related to the importance of precise cell lineage (alpha beta-type T cell, gamma delta T cell, or NK cell), the implications of Epstein-Barr virus infection, the significance of anatomic location including nodal disease, and the question of further categorization of enteropathy-associated T-cell lymphomas. Finally, developments subsequent to the 2008 World Health Organization Classification, including the recognition of indolent NK-cell and T-cell disorders of the gastrointestinal tract are presented.
引用
收藏
页码:E60 / E71
页数:12
相关论文
共 50 条
  • [21] A phse I/II trial of clofarabine in patients with relapsed T-cell or NK-cell lymphomas
    Mulford, D. A.
    Pohiman, B. L.
    Hamlin, P. A.
    Young, F.
    Pamer, E.
    Horwitz, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Extranodal peripheral T-cell and NK-cell neoplasms
    Jaffe, ES
    Krenacs, L
    Kumar, S
    Kingma, DW
    Raffeld, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (01) : S46 - S55
  • [23] Opposing functions of activatory T-cell receptors and inhibitory NK-cell receptors on cytotoxic T cells
    Ciccone, E
    Grossi, CE
    Velardi, A
    IMMUNOLOGY TODAY, 1996, 17 (10): : 450 - 453
  • [24] Clinical trials for T/NK-cell lymphomas in Japan
    Tobinai, Kensei
    ANNALS OF ONCOLOGY, 2015, 26 : 17 - 17
  • [25] T-cell and NK-cell posttransplantation lymphoproliferative disorders
    Swerdlow, Steven H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (06) : 887 - 895
  • [26] NK/T-cell lymphomas in children
    Lai, Catherine
    Dunleavy, Kieron
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (01) : 33 - 41
  • [27] NK-/T-cell lymphomas
    Wang, Hua
    Fu, Bi-bo
    Gale, Robert Peter
    Liang, Yang
    LEUKEMIA, 2021, 35 (09) : 2460 - 2468
  • [28] NK-/T-cell lymphomas
    Hua Wang
    Bi-bo Fu
    Robert Peter Gale
    Yang Liang
    Leukemia, 2021, 35 : 2460 - 2468
  • [29] Cutaneous T-cell and NK-cell lymphomas - The WHO-EORTC classification of specialized tumor types
    Kinney, Marsha C.
    Jones, Dan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (05) : 670 - 686
  • [30] Next Questions: T-Cell Lymphomas
    Broccoli, Alessandro
    Zinzani, Pier Luigi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S111 - S112